Clinical Trials Browser

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Clinical Trials

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

SOHO-02

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Bronchoscopic Cryo-Immunotherapy of Lung Cancer

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC

Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

Optim-UCPVax

Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

VIC-1911

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer

Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)